Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...

FDA grants orphan drug status to orziloben for intestinal failure-associated liver disease (90)Orziloben secures FDA orphan drug status in intestinal failure-associated liver disease (87) ...

In decompensated alcohol-related cirrhosis, sustained alcohol abstinence is highly associated with liver recompensation, improved function, and more.

Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.

The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...

Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global health issue. MAFLD is closely linked to ...

Mounting evidence has shown that the gut microbiota plays an essential role in human health and diseases and has been considered as therapeutic target in various chronic diseases. The diversity and ...

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...

London, UK - 3 March, 2026 - Quell Therapeutics Ltd ('Quell”), today announced that it has initiated a Phase 1/2 basket clinical study evaluating its autologous CAR-Treg therapy, QEL-005, in patients ...

Protective Effects of Vitamin D in Necrotizing Enterocolitis of Preterm Infants: From Basic Research to Clinical Translation. Journal of Biosciences and Medicines, 14, 42-56. doi: ...

This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...

Liver-related side effects have led some analysts to question fenebrutinib’s prospects, even though the drug has now cleared Phase 3 studies in multiple forms of the disease.